CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

July 4, 2024

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Mao Zedong Statue unveiled

July 4, 2024

WINDHOEK: Deputy Prime Minister John Mutorwa has implored the National Heritage Council of Namibia to consider granting the Mao Zedong statue the status of Namibian and Chinese Heritage.

Mutorwa, in a speech read on his behalf during the unveiling of…